Search by Drug Name or NDC
NDC 70436-0202-03 Metoprolol succinate 25 mg/1 Details
Metoprolol succinate 25 mg/1
Metoprolol succinate is a ORAL TABLET, EXTENDED RELEASE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Slate Run Pharmaceuticals, LLC. The primary component is METOPROLOL SUCCINATE.
Product Information
| NDC | 70436-0202 |
|---|---|
| Product ID | 70436-202_0be686f0-10ed-a18c-e063-6294a90ae686 |
| Associated GPIs | |
| GCN Sequence Number | 047586 |
| GCN Sequence Number Description | metoprolol succinate TAB ER 24H 25 MG ORAL |
| HIC3 | J7C |
| HIC3 Description | BETA-ADRENERGIC BLOCKING AGENTS |
| GCN | 12947 |
| HICL Sequence Number | 006323 |
| HICL Sequence Number Description | METOPROLOL SUCCINATE |
| Brand/Generic | Generic |
| Proprietary Name | Metoprolol succinate |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Metoprolol succinate |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET, EXTENDED RELEASE |
| Route | ORAL |
| Active Ingredient Strength | 25 |
| Active Ingredient Units | mg/1 |
| Substance Name | METOPROLOL SUCCINATE |
| Labeler Name | Slate Run Pharmaceuticals, LLC |
| Pharmaceutical Class | Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA213854 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 70436-0202-03 (70436020203)
| NDC Package Code | 70436-202-03 |
|---|---|
| Billing NDC | 70436020203 |
| Package | 1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (70436-202-03) |
| Marketing Start Date | 2022-10-28 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |